Calithera Biosciences Funding & Investors
Calithera Biosciences is a development-stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a pipeline of unique anti- cancer drugs that selectively target metabolic and apoptotic pathways critical to tumor growth and survival.
calithera.comTotal Amount Raised: $341,400,000
Calithera Biosciences Funding Rounds
Post Ipo Equity
$10,000,000
Grant
$2,400,000
Grant Investors
Cystic Fibrosis FoundationPost Ipo Equity
$36,000,000
Post Ipo Equity
$57,500,000
Post Ipo Equity
$50,000,000
Post Ipo Equity
$80,500,000
Series Unknown
$15,999,998
Series D
$35,000,000
Series D Investors
Delphi VenturesLongwood Fund ManagementAdage Capital ManagementMorgenthalerAdvanced Technology VenturesPost Ipo Equity
$10,000,000
Grant
$2,400,000
Grant Investors
Cystic Fibrosis FoundationPost Ipo Equity
$36,000,000
Post Ipo Equity
$57,500,000
Post Ipo Equity
$50,000,000
Post Ipo Equity
$80,500,000
Series Unknown
$15,999,998
Series D
$35,000,000
Series D Investors
Delphi VenturesLongwood Fund ManagementAdage Capital ManagementMorgenthalerAdvanced Technology VenturesSeries C
$2,000,000
Series C Investors
Delphi VenturesMorgenthalerAdvanced Technology VenturesSeries C
$2,000,000
Series C Investors
Delphi VenturesMorgenthalerAdvanced Technology VenturesSeries B
$8,000,000
Series Unknown
$4,000,000
Series Unknown Investors
Delphi VenturesU.S. Venture PartnersAdvanced Technology VenturesMorgenthalerSeries A
$40,000,000
Series A Investors
Delphi VenturesU.S. Venture PartnersMorgenthalerMission Bay CapitalAdvanced Technology Ventures